Foxo Technologies Inc. (FOXO): Total Liabilities

Annual figures by period end, from SEC filings.

$33.50M
As of 2025-12-31
$44.98M
As of 2026-06-30
+5.3%
3-year compound annual growth
+13.1%
5-year compound annual growth
$55.52M2020-12-31: $18.08M2021-12-31: $55.52M2022-12-31: $28.70M2023-12-31: $14.83M2024-12-31: $36.44M2025-12-31: $33.50M$33.50M
2020-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$33.50M-8.1%2026-04-15, Balance as of period end
2024-12-31$36.44M+145.8%2026-04-15, Balance as of period end
2023-12-31$14.83M-48.3%2025-04-15, Balance as of period end
2022-12-31$28.70M-48.3%2024-06-06, Balance as of period end
2021-12-31$55.52M+207.0%2023-03-31, Balance as of period end
2020-12-31$18.08Mn/a2022-03-07, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
Foxo Technologies Inc. (FOXO)2025-12-31$33.50M-8.1%
OmniAb, Inc. (OABI)2025-12-31$33.89M-10.7%
MaxCyte, Inc. (MXCT)2025-12-31$31.02M-6.6%
bioAffinity Technologies, Inc. (BIAF)2025-12-31$3.68M-5.8%
Absci Corp (ABSI)2025-12-31$26.85M-22.1%
NRC Health (NRC)2025-12-31$120.89M+19.4%
iSpecimen Inc. (ISPC)2025-12-31$6.44M+6.7%
OneMedNet Corp (ONMD)2025-12-31$5.12M-74.0%
Cannabis Bioscience International Holdings, Inc. (CBIH)2025-05-31$1.20M+5.2%

Compare FOXO, OABI, MXCT, BIAF side by side · Screen every company in Services-Commercial Physical & Biological Research ↗